View in EDS HTML Full Text PDF Full Text

Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations.

Saved in:
Bibliographic Details
Title: Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations.
Authors: Gallus M; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA., Young JS; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA., Cook Quackenbush S; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA., Khasraw M; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA., de Groot J; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA., Okada H; The Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA.
Source: Neuro-oncology [Neuro Oncol] 2025 Feb 10; Vol. 27 (2), pp. 352-368.
Publication Type: Journal Article; Review
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39450490
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gallus+M%22">Gallus M</searchLink>; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Young+JS%22">Young JS</searchLink>; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Cook+Quackenbush+S%22">Cook Quackenbush S</searchLink>; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Khasraw+M%22">Khasraw M</searchLink>; The Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22de+Groot+J%22">de Groot J</searchLink>; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Okada+H%22">Okada H</searchLink>; The Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Neurological Surgery, Unversity of California San Fracisco, San Francisco, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2025 Feb 10; Vol. 27 (2), pp. 352-368.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39450490
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/noae203
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 352
    Titles:
      – TitleFull: Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gallus M
      – PersonEntity:
          Name:
            NameFull: Young JS
      – PersonEntity:
          Name:
            NameFull: Cook Quackenbush S
      – PersonEntity:
          Name:
            NameFull: Khasraw M
      – PersonEntity:
          Name:
            NameFull: de Groot J
      – PersonEntity:
          Name:
            NameFull: Okada H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 02
              Text: 2025 Feb 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1